REGN Regeneron Pharmaceuticals, Inc.

Fundamentals / CIK 0000872589 / USD

Regeneron Pharmaceuticals, Inc. reported $16.90B in revenue and net income of $4.82B for the trailing twelve months ended September 30, 2026 (up 36.3% year over year), with a 28.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open REGN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$15.84B$7.92B$0FY 2016 Revenue: $4.86BFY 2016 Net Income: $895.5M2016FY 2017 Revenue: $5.87BFY 2017 Net Income: $1.20B2017FY 2018 Revenue: $5.15BFY 2018 Net Income: $2.44B2018FY 2019 Revenue: $6.56BFY 2019 Net Income: $2.12B2019FY 2020 Revenue: $8.50BFY 2020 Net Income: $3.51B2020FY 2021 Revenue: $16.07BFY 2021 Net Income: $8.08B2021FY 2022 Revenue: $12.17BFY 2022 Net Income: $4.34B2022FY 2023 Revenue: $13.12BFY 2023 Net Income: $3.95B2023FY 2024 Revenue: $14.20BFY 2024 Net Income: $4.41B2024FY 2025 Revenue: $14.34BFY 2025 Net Income: $4.50B2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $14.34B $14.20B $13.12B $12.17B $16.07B $8.50B $6.56B $5.15B $5.87B $4.86B
Cost of Revenue -- -- -- -- -- -- $402.8M $237.5M $202.5M $194.6M
Gross Profit -- -- -- -- -- -- $6.15B $4.91B $5.67B $4.67B
Research & Development $5.85B $5.13B $4.44B $3.59B $2.86B $2.65B $2.45B $1.47B $2.08B $2.05B
Selling, General & Admin $2.70B $2.95B $2.63B $2.12B $1.82B $1.35B $1.34B $1.13B $1.32B $1.18B
Operating Income $3.58B $3.99B $4.05B $4.74B $8.95B $3.58B $2.21B $2.53B $2.08B $1.33B
EBITDA $4.12B $4.47B $4.47B $5.08B $9.23B $3.81B $2.42B $2.68B $2.23B $1.44B
Interest Expense $43.80M $55.20M $73.00M $59.40M $57.30M $56.90M $30.20M $28.20M $25.10M $7.20M
Income Before Tax $5.23B $4.78B $4.20B $4.86B $9.33B $3.81B $2.43B $2.55B $2.08B $1.33B
Income Tax Expense $725.8M $367.3M $245.7M $520.4M $1.25B $297.2M $313.3M $109.1M $880.0M $434.3M
Net Income $4.50B $4.41B $3.95B $4.34B $8.08B $3.51B $2.12B $2.44B $1.20B $895.5M
Basic EPS $43.07 $40.90 $37.05 $40.51 $76.40 $32.65 $19.38 $22.65 $11.27 $8.55
Diluted EPS $41.48 $38.34 $34.77 $38.22 $71.97 $30.52 $18.46 $21.29 $10.34 $7.70
Basic Shares Outstanding 104.6M 107.9M 106.7M 107.1M 105.7M 107.6M 109.2M 107.9M 106.3M 104.7M
Diluted Shares Outstanding 108.6M 115.1M 113.7M 113.5M 112.2M 115.1M 114.6M 114.8M 115.9M 116.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $5.12B $4.29B $3.61B $3.88B $3.75B $3.68B $3.03B $3.79B
Research & Development $1.79B $1.63B $1.54B $1.63B $1.48B $1.42B $1.33B $1.41B
Selling, General & Admin $677.8M $662.1M $647.7M $775.0M $657.8M $634.2M $633.0M $792.2M
Operating Income $2.05B $1.29B $642.9M $879.9M $1.03B $1.08B $591.7M $990.2M
EBITDA $2.17B $1.42B $766.1M $1.02B $1.16B $1.21B $718.6M $1.12B
Interest Expense $10.60M $11.00M $12.90M $12.20M $19.30M $3.60M $8.70M $10.50M
Income Before Tax $2.28B $1.53B $831.2M $1.04B $1.76B $1.52B $905.0M $958.1M
Income Tax Expense $335.4M $230.9M $104.0M $199.1M $303.3M $127.1M $96.30M $40.40M
Net Income $1.95B $1.30B $727.2M $844.6M $1.46B $1.39B $808.7M $917.7M
Basic EPS $19.16 $12.62 $6.99 -- $14.09 $13.24 $7.58 --
Diluted EPS $18.45 $12.23 $6.75 -- $13.62 $12.81 $7.27 --
Basic Shares Outstanding 101.7M 102.8M 104.0M -- 103.6M 105.1M 106.7M --
Diluted Shares Outstanding 105.6M 106.0M 107.7M -- 107.2M 108.6M 111.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.12B $2.49B $2.73B $3.11B $2.89B $2.19B $1.62B $1.47B $812.7M $535.2M
Short-Term Investments $5.49B $6.52B $8.11B $4.64B $2.81B $1.39B $1.60B $1.34B $596.8M $503.5M
Cash & Short-Term Investments $8.61B $9.01B $10.84B $7.74B $5.69B $3.59B $3.21B $2.81B $1.41B $1.04B
Accounts Receivable, Net $5.74B $6.21B $5.67B $5.33B $6.04B $4.11B $2.10B $1.72B $1.54B $1.34B
Inventory $3.20B $3.09B $2.58B $2.40B $1.95B $1.92B $1.42B $1.15B $726.1M $399.4M
Total Current Assets $18.02B $18.66B $19.48B $15.88B $14.01B $9.78B $7.69B $6.45B $4.33B $3.18B
Property, Plant & Equipment, Net $5.12B $4.60B $4.15B $3.76B $3.48B $3.22B $2.89B $2.58B $2.36B $2.08B
Intangible Assets $1.26B $1.15B $1.04B $915.5M $6.70M -- -- -- -- --
Long-Term Investments $10.26B $8.90B $5.40B $6.59B $6.84B $3.14B $3.26B $1.75B $1.49B $864.3M
Other Non-Current Assets $1.82B $1.14B $444.1M $336.4M $216.1M $168.1M $144.7M $127.4M $77.90M $20.29M
Total Non-Current Assets $22.54B $19.10B $13.60B $13.33B $11.42B $7.38B $7.12B $5.29B $4.43B $3.79B
Total Assets $40.56B $37.76B $33.08B $29.21B $25.43B $17.16B $14.81B $11.73B $8.76B $6.97B
Accounts Payable $939.0M $789.5M $606.6M $589.2M $564.0M $475.5M $418.1M $218.2M $178.2M $135.0M
Short-Term Debt -- -- -- -- -- -- $0 -- -- --
Deferred Revenue (Current) $553.0M $627.7M $458.9M $477.9M $442.0M $577.7M $591.7M $452.5M $320.1M $231.7M
Other Current Liabilities -- -- -- -- -- $122.4M $85.00M -- $267K $1.18M
Total Current Liabilities $4.37B $3.94B $3.42B $3.14B $3.93B $2.70B $2.10B $1.44B $1.14B $1.24B
Long-Term Debt $1.99B $1.98B $1.98B $1.98B $1.98B $1.98B $0 -- -- --
Deferred Revenue (Non-Current) $208.7M $185.7M $126.7M $69.80M $73.30M $57.80M $619.0M $464.2M $629.2M $830.8M
Other Non-Current Liabilities $2.02B $1.57B $854.1M $638.0M $680.2M $687.1M $317.7M $361.7M $152.0M $100.4M
Total Non-Current Liabilities $4.93B $4.46B $3.68B $3.41B $2.73B $3.44B $1.62B $1.53B $1.48B $1.28B
Total Liabilities $9.30B $8.41B $7.11B $6.55B $6.67B $6.14B $3.72B $2.98B $2.62B $2.52B
Total Debt (incl. Leases) $2.97B $2.94B $2.79B $2.77B $2.70B $2.70B $737.5M -- -- --
Retained Earnings $35.80B $31.67B $27.26B $23.31B $18.97B $10.89B $7.38B $5.25B $2.95B $1.75B
Accumulated Other Comp. Income $77.50M -$7.90M -$80.90M -$238.8M -$26.20M $29.30M $21.10M -$12.30M $600K -$12.84M
Total Stockholders' Equity $31.26B $29.35B $25.97B $22.66B $18.77B $11.03B $11.09B $8.76B $6.14B $4.45B
Total Equity $31.26B $29.35B $25.97B $22.66B $18.77B $11.03B $11.09B $8.76B $6.14B $4.45B

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.66B $2.46B $2.96B $3.12B $2.51B $2.00B $3.09B $2.49B
Short-Term Investments $5.64B $5.54B $5.79B $5.49B $5.94B $5.47B $5.26B $6.52B
Cash & Short-Term Investments $9.30B $7.99B $8.75B $8.61B $8.44B $7.47B $8.35B $9.01B
Accounts Receivable, Net $7.58B $6.57B $5.73B $5.74B $5.69B $5.61B $5.56B $6.21B
Inventory $2.89B $3.08B $3.10B $3.20B $3.25B $3.21B $3.19B $3.09B
Total Current Assets $20.80B $18.45B $18.21B $18.02B $17.98B $16.86B $17.57B $18.66B
Property, Plant & Equipment, Net $5.73B $5.46B $5.27B $5.12B $5.00B $4.84B $4.69B $4.60B
Intangible Assets $1.32B $1.31B $1.29B $1.26B $1.38B $1.35B $1.17B $1.15B
Long-Term Investments $9.56B $9.83B $9.79B $10.26B $10.29B $10.06B $9.28B $8.90B
Other Non-Current Assets $2.47B $2.31B $2.13B $1.82B $1.67B $1.54B $1.39B $1.14B
Total Non-Current Assets $23.61B $23.28B $22.66B $22.54B $22.19B $21.36B $19.97B $19.10B
Total Assets $44.41B $41.73B $40.87B $40.56B $40.17B $38.22B $37.55B $37.76B
Accounts Payable $1.14B $1.16B $1.03B $939.0M $903.8M $723.9M $705.5M $789.5M
Deferred Revenue (Current) $749.8M $684.8M $636.2M $553.0M $545.6M $481.9M $619.3M $627.7M
Total Current Liabilities $6.20B $5.53B $5.11B $4.37B $4.43B $3.67B $3.57B $3.94B
Long-Term Debt $1.99B $1.99B $1.99B $1.99B $1.99B $1.99B $1.98B $1.98B
Deferred Revenue (Non-Current) $220.2M $220.4M $225.1M $208.7M $219.2M $206.3M $211.8M $185.7M
Other Non-Current Liabilities $2.50B $2.28B $2.13B $2.02B $1.86B $1.70B $1.67B $1.57B
Total Non-Current Liabilities $4.70B $4.49B $4.34B $4.93B $4.79B $4.61B $4.59B $4.46B
Total Liabilities $10.91B $10.02B $9.45B $9.30B $9.21B $8.28B $8.16B $8.41B
Total Debt (incl. Leases) $2.71B $2.71B $2.71B $2.97B $2.71B $2.71B $2.70B $2.94B
Retained Earnings $39.47B $37.62B $36.42B $35.80B $35.05B $33.68B $32.38B $31.67B
Accumulated Other Comp. Income -$197.5M -$35.80M $11.90M $77.50M $69.00M $52.50M $29.10M -$7.90M
Total Stockholders' Equity $33.50B $31.71B $31.42B $31.26B $30.96B $29.94B $29.39B $29.35B
Total Equity $33.50B $31.71B $31.42B $31.26B $30.96B $29.94B $29.39B $29.35B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $4.50B $4.41B $3.95B $4.34B $8.08B $3.51B $2.12B $2.44B $1.20B $895.5M
Depreciation & Amortization $543.7M $482.9M $421.0M $341.4M $286.2M $235.9M $210.3M $148.2M $145.5M $104.7M
Stock-Based Compensation $993.7M $982.8M $885.0M $725.0M $601.7M $432.0M $464.3M $427.4M $507.3M $559.9M
Change in Receivables $498.1M -$554.0M -$338.8M $707.8M -$1.93B -$1.36B -$523.7M -$236.4M -$362.7M -$143.8M
Change in Inventory -$275.3M -$619.7M -$271.7M -$696.5M -$494.3M -$529.4M -$335.5M -$387.9M -$314.2M -$149.8M
Operating Cash Flow $4.98B $4.42B $4.59B $5.01B $7.08B $2.62B $2.43B $2.20B $1.31B $1.49B
Capital Expenditure -$898.4M -$755.9M -$718.6M -$590.1M -$551.9M -$614.6M -$429.6M -$383.1M -$272.6M -$511.9M
Free Cash Flow $4.08B $3.66B $3.88B $4.42B $6.53B $2.00B $2.00B $1.81B $1.03B $974.0M
Acquisitions, Net -$3.30M -$16.50M -$54.90M -$230.3M $0 -- -- -- -- --
Purchases of Investments -$10.96B -$16.62B -$11.65B -$7.49B -$7.05B -$3.24B -$3.20B -$1.85B -$1.28B -$809.4M
Investing Cash Flow -$629.1M -$2.47B -$3.19B -$3.78B -$5.38B -$70.60M -$2.03B -$1.46B -$1.01B -$1.05B
Common Stock Issued $635.9M $1.47B $1.15B $1.52B $1.67B $2.58B $211.8M $114.5M $240.2M $126.7M
Share Repurchases -$3.44B -$2.60B -$2.23B -$2.08B -$1.65B -$5.85B -$275.9M -$4.40M $0 $0
Dividends Paid -$370.3M $0 $0 -- -- -- -- -- -- --
Financing Cash Flow -$3.72B -$2.20B -$1.79B -$1.01B -$1.01B -$1.97B -$252.1M -$77.10M -$24.40M -$700.5M
Net Change in Cash $634.7M -$248.8M -$381.6M $221.3M $690.8M $577.0M $150.1M $655.0M $277.5M -$261.4M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $1.95B $1.30B $727.2M $844.6M $1.46B $1.39B $808.7M $917.7M
Depreciation & Amortization $121.0M $123.7M $123.2M $145.0M $136.7M $135.1M $126.9M $126.4M
Stock-Based Compensation $255.8M $243.0M $257.4M $249.3M $237.0M $251.7M $255.7M $304.4M
Change in Receivables -$1.01B -$838.5M $1.20M -$51.20M -$80.30M -$28.20M $657.8M -$117.8M
Change in Inventory $112.3M -$28.20M $26.60M $2.10M -$82.60M -$42.50M -$152.3M -$117.7M
Operating Cash Flow $1.78B $813.0M $1.08B $1.17B $1.62B $1.14B $1.05B $1.26B
Capital Expenditure -$300.2M -$240.2M -$230.6M -$248.7M -$201.4M -$219.0M -$229.3M -$199.6M
Free Cash Flow $1.48B $572.8M $848.3M $922.0M $1.42B $925.4M $815.8M $1.06B
Purchases of Investments -$1.53B -$1.95B -$2.76B -$2.04B -$3.52B -$2.86B -$2.54B -$1.95B
Investing Cash Flow -$288.1M -$92.70M -$428.9M $220.3M -$402.9M -$1.09B $647.5M $350.6M
Common Stock Issued $300.9M $49.20M $163.1M $503.5M $40.30M $31.50M $60.60M $90.90M
Share Repurchases -$399.7M -$1.17B -$794.3M -$671.7M -$664.0M -$1.06B -$1.04B -$973.0M
Dividends Paid -$95.70M -$96.80M -$97.80M -$92.70M -$91.20M -$92.60M -$93.80M $0
Financing Cash Flow -$290.2M -$1.22B -$802.2M -$780.1M -$717.9M -$1.13B -$1.09B -$1.14B
Net Change in Cash $1.21B -$504.6M -$153.1M $610.6M $497.5M -$1.08B $604.0M $477.2M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- 93.9% 95.4% 96.6% 96.0%
Operating Margin 24.9% 28.1% 30.9% 38.9% 55.7% 42.1% 33.7% 49.3% 35.4% 27.4%
Net Profit Margin 31.4% 31.1% 30.1% 35.6% 50.2% 41.3% 32.3% 47.5% 20.4% 18.4%
Return on Equity (ROE) 14.4% 15.0% 15.2% 19.1% 43.0% 31.9% 19.1% 27.9% 19.5% 20.1%
Return on Assets (ROA) 11.1% 11.7% 12.0% 14.9% 31.7% 20.5% 14.3% 20.8% 13.7% 12.8%
Current Ratio 4.13x 4.73x 5.69x 5.06x 3.56x 3.63x 3.67x 4.47x 3.82x 2.56x
Quick Ratio 3.39x 3.95x 4.94x 4.29x 3.07x 2.91x 2.99x 3.67x 3.18x 2.24x
Debt to Equity 0.10x 0.10x 0.11x 0.12x 0.14x 0.24x 0.07x -- -- --
Revenue Growth (YoY) +1.0% +8.3% +7.8% -24.3% +89.1% +29.6% +27.4% -12.4% +20.8% +18.4%
Gross Profit Growth (YoY) -- -- -- -- -- -- +25.4% -13.4% +21.5% +20.8%
Operating Income Growth (YoY) -10.3% -1.4% -14.6% -47.0% +150.1% +61.9% -12.8% +21.9% +56.3% +6.3%
Net Income Growth (YoY) +2.1% +11.6% -8.9% -46.3% +129.9% +66.0% -13.4% +104.0% +33.8% +40.8%
EPS Growth (YoY) +5.3% +10.4% -8.5% -47.0% +134.0% +68.5% -14.4% +101.0% +31.8% +38.6%
Operating Cash Flow Growth (YoY) +12.6% -3.8% -8.4% -29.2% +170.5% +7.7% +10.7% +67.9% -12.0% +11.7%
Free Cash Flow Growth (YoY) +11.3% -5.4% -12.4% -32.2% +225.9% +0.2% +10.4% +75.2% +6.2% +49.2%
5Y Revenue / Share Growth +73.6% +119.2% +157.8% +105.7% +227.5% +98.3% +114.3% +121.9% +279.4% +843.5%
10Y Revenue / Share Growth +244.4% +369.7% +471.9% +680.7% +2990.3% +1326.5% -- -- -- --
5Y Net Income / Share Growth +31.9% +111.1% +63.6% +259.3% +793.2% +429.0% +476.5% +436.1% +42.3% --
10Y Net Income / Share Growth +597.8% +1116.9% +776.9% +411.2% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin 28.8% 24.7% 24.3% 24.9% 25.9% 27.0% 27.2% 28.1%
Net Profit Margin 28.5% 27.9% 29.6% 31.4% 32.1% 31.4% 31.9% 31.1%
Return on Equity (ROE) 14.4% 13.7% 14.1% 14.4% 14.8% 14.9% 15.3% 15.0%
Return on Assets (ROA) 10.8% 10.4% 10.8% 11.1% 11.4% 11.7% 12.0% 11.7%
Current Ratio 3.35x 3.34x 3.57x 4.13x 4.06x 4.60x 4.93x 4.73x
Quick Ratio 2.89x 2.78x 2.96x 3.39x 3.33x 3.72x 4.03x 3.95x
Debt to Equity 0.08x 0.09x 0.09x 0.10x 0.09x 0.09x 0.09x 0.10x
Revenue Growth (YoY) +36.3% +16.7% +19.0% +2.5% +0.9% +3.6% -3.7% +10.3%
Operating Income Growth (YoY) +99.5% +19.8% +8.7% -11.1% -12.9% +0.9% -21.3% +1.8%
Net Income Growth (YoY) +33.5% -6.8% -10.1% -8.0% +8.9% -2.8% +12.0% -20.9%
EPS Growth (YoY) +36.0% -4.7% -7.8% -- +13.6% -0.1% +13.1% --
Operating Cash Flow Growth (YoY) +10.2% -29.0% +3.2% -7.3% +25.4% +223.3% -30.9% +15.9%
Free Cash Flow Growth (YoY) +4.6% -38.1% +4.0% -13.3% +35.1% +433.4% -40.8% +26.8%
Source: SEC EDGAR CompanyFacts (CIK 0000872589) · from December 31, 2008 Data through September 30, 2026 · synced Nov 20, 2026, 05:01 UTC · Open in terminal